The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

Pain in the back of your knee when walking? Learn the causes, symptoms, and best treatments to relieve discomfort and prevent ...

A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, ...

A discussion of a challenging case of renal artery denervation for resistant hypertension. Hypertension (HTN) is estimated to ...

• Antibiotics seem to reduce surgical site infections in people undergoing aortic or aortoiliac surgery. • Other interventions assessed appear to make little or no difference in reducing the incidence ...

The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium ...

Orchestra BioMed Holdings, Inc.’s OBIO share price has surged by 6.59%, which has investors questioning if this is right time ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce ...